A Phase II, Multicenter, Randomized, Placebo-Controlled, Double-Masked Trial of A Topical Estradiol Ophthalmic Formulation in Post-Menopausal Women With Moderate-To-Severe Dry Eye Disease
mediaposted on 2021-03-09, 12:39 authored by figshare admin adisjournalsfigshare admin adisjournals, Doreen Schmidl, László Szalai, Orsolya G. Kiss, Leopold Schmetterer, Gerhard Garhöfer
Article full text
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.